Agilent Technologies Inc
A113.500USD
-1.310-1.14%
Handelsschluss 08/01, 16:00（ET）Kurse um 15 Minuten verzögert
32.23BMarktkapitalisierung
27.64KGV TTM
mehr Informationen über Agilent Technologies Inc Unternehmen
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Unternehmensinformationen
BörsenkürzelA
Name des UnternehmensAgilent Technologies Inc
IPO-datumNov 18, 1999
Gegründet am1999
CEOMr. Padraig Mcdonnell
Anzahl der mitarbeiter17900
WertpapierartOrdinary Share
GeschäftsjahresendeNov 18
Addresse5301 Stevens Creek Blvd
StadtSANTA CLARA
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl95051
Telefon14083458886
Websitehttps://www.agilent.com/
BörsenkürzelA
IPO-datumNov 18, 1999
Gegründet am1999
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Boon Hwee Koh
Mr. Boon Hwee Koh
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
61.55K
+2.11%
Mr. Rodney Gonsalves
Mr. Rodney Gonsalves
Interim Chief Financial Officer, Principal Accounting Officer, Vice President, Corporate Controller
Interim Chief Financial Officer, Principal Accounting Officer, Vice President, Corporate Controller
48.45K
+22.91%
Dr. George A. Scangos, Ph.D.
Dr. George A. Scangos, Ph.D.
Independent Director
Independent Director
38.35K
+4.98%
Dr. Daniel K. Podolsky, M.D.
Dr. Daniel K. Podolsky, M.D.
Independent Director
Independent Director
35.68K
--
Mr. Dow R. Wilson
Mr. Dow R. Wilson
Independent Director
Independent Director
18.04K
+11.21%
Ms. Mala Anand
Ms. Mala Anand
Independent Director
Independent Director
14.55K
+14.29%
Dr. Otis W. Brawley, M.D.
Dr. Otis W. Brawley, M.D.
Independent Director
Independent Director
10.73K
+32.49%
Mr. Padraig Mcdonnell
Mr. Padraig Mcdonnell
Chief Executive Officer, Director
Chief Executive Officer, Director
10.26K
-12.81%
Dr. Mikael G. Dolsten, M.D., Ph.D.
Dr. Mikael G. Dolsten, M.D., Ph.D.
Independent Director
Independent Director
7.54K
+31.77%
Dr. Simon May
Dr. Simon May
Senior Vice President, President, Diagnostics and Genomics
Senior Vice President, President, Diagnostics and Genomics
7.32K
-4.79%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Boon Hwee Koh
Mr. Boon Hwee Koh
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
61.55K
+2.11%
Mr. Rodney Gonsalves
Mr. Rodney Gonsalves
Interim Chief Financial Officer, Principal Accounting Officer, Vice President, Corporate Controller
Interim Chief Financial Officer, Principal Accounting Officer, Vice President, Corporate Controller
48.45K
+22.91%
Dr. George A. Scangos, Ph.D.
Dr. George A. Scangos, Ph.D.
Independent Director
Independent Director
38.35K
+4.98%
Dr. Daniel K. Podolsky, M.D.
Dr. Daniel K. Podolsky, M.D.
Independent Director
Independent Director
35.68K
--
Mr. Dow R. Wilson
Mr. Dow R. Wilson
Independent Director
Independent Director
18.04K
+11.21%
Ms. Mala Anand
Ms. Mala Anand
Independent Director
Independent Director
14.55K
+14.29%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Non-instrumentation and other
1.12B
67.03%
Instrumentation
550.00M
32.97%
Nach RegionUSD
Name
Umsatz
Anteil
United States
678.00M
40.65%
Asia Pacific
548.00M
32.85%
Europe
442.00M
26.50%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Non-instrumentation and other
1.12B
67.03%
Instrumentation
550.00M
32.97%
Aktionärsstatistik
Aktualisiert: Thu, May 15
Aktualisiert: Thu, May 15
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
11.72%
BlackRock Institutional Trust Company, N.A.
5.41%
State Street Global Advisors (US)
4.44%
MFS Investment Management
3.87%
Wellington Management Company, LLP
3.14%
Other
71.43%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
11.72%
BlackRock Institutional Trust Company, N.A.
5.41%
State Street Global Advisors (US)
4.44%
MFS Investment Management
3.87%
Wellington Management Company, LLP
3.14%
Other
71.43%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
44.06%
Investment Advisor/Hedge Fund
34.43%
Hedge Fund
4.41%
Research Firm
1.97%
Pension Fund
1.82%
Insurance Company
1.66%
Bank and Trust
1.57%
Sovereign Wealth Fund
1.30%
Family Office
0.44%
Other
8.34%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
2097
260.64M
91.75%
-4.22M
2025Q1
2174
262.93M
92.55%
-7.77M
2024Q4
2144
261.66M
91.77%
-9.44M
2024Q3
2092
261.54M
91.00%
-12.94M
2024Q2
2065
263.61M
90.36%
-18.36M
2024Q1
2066
270.62M
92.35%
-9.44M
2023Q4
2084
269.59M
92.01%
-3.30M
2023Q3
2017
262.63M
89.76%
-13.56M
2023Q2
2002
268.16M
90.78%
-20.64M
2023Q1
1985
271.86M
91.93%
-13.10M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
33.28M
11.72%
+239.78K
+0.73%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
15.37M
5.41%
+39.00K
+0.25%
Mar 31, 2025
State Street Global Advisors (US)
12.61M
4.44%
-104.71K
-0.82%
Mar 31, 2025
MFS Investment Management
10.98M
3.87%
-512.88K
-4.46%
Mar 31, 2025
Wellington Management Company, LLP
8.93M
3.14%
-376.03K
-4.04%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
7.60M
2.68%
-629.16K
-7.65%
Mar 31, 2025
Geode Capital Management, L.L.C.
7.20M
2.54%
+201.68K
+2.88%
Mar 31, 2025
Pictet Asset Management Ltd.
5.34M
1.88%
+128.13K
+2.46%
Mar 31, 2025
Generation Investment Management LLP
4.98M
1.75%
+824.24K
+19.82%
Mar 31, 2025
State Farm Insurance Companies
4.52M
1.59%
--
--
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: 11 hours ago
Aktualisiert: 11 hours ago
Name
Anteil
Honeytree US Equity ETF
4.01%
First Trust Water ETF
3.56%
VanEck Morningstar Wide Moat Growth ETF
2.44%
VanEck Morningstar Wide Moat ETF
2.38%
Global X Genomics & Biotechnology ETF
2.2%
First Trust Indxx Medical Devices ETF
2.15%
Invesco Raymond James SB-1 Equity ETF
2.12%
Argent Mid Cap ETF
2.1%
iShares Health Innovation Active ETF
2.01%
Invesco S&P 500 Equal Weight Health Care ETF
1.63%
Mehr Anzeigen
Honeytree US Equity ETF
Anteil4.01%
First Trust Water ETF
Anteil3.56%
VanEck Morningstar Wide Moat Growth ETF
Anteil2.44%
VanEck Morningstar Wide Moat ETF
Anteil2.38%
Global X Genomics & Biotechnology ETF
Anteil2.2%
First Trust Indxx Medical Devices ETF
Anteil2.15%
Invesco Raymond James SB-1 Equity ETF
Anteil2.12%
Argent Mid Cap ETF
Anteil2.1%
iShares Health Innovation Active ETF
Anteil2.01%
Invesco S&P 500 Equal Weight Health Care ETF
Anteil1.63%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
1.25B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Nov 20, 2024
A.NB Interim Cash Dividend of gross USD 0.248 paid on Jan 22, 2025 going ex on Dec 31, 2024 with reinvestment option
Dec 31, 2024
Jan 22, 2025
Dec 31, 2024
Sep 18, 2024
A.NB Final Cash Dividend of gross USD 0.236 paid on Oct 23, 2024 going ex on Oct 01, 2024 with reinvestment option
Oct 01, 2024
Oct 23, 2024
Oct 01, 2024
May 22, 2024
A.NB Interim Cash Dividend of gross USD 0.236 paid on Jul 24, 2024 going ex on Jul 02, 2024
Jul 02, 2024
Jul 24, 2024
Jul 02, 2024
Feb 21, 2024
A.NB Interim Cash Dividend of gross USD 0.236 paid on Apr 24, 2024 going ex on Apr 01, 2024
Apr 02, 2024
Apr 24, 2024
Apr 01, 2024
Nov 16, 2023
A.NB Interim Cash Dividend of gross USD 0.236 paid on Jan 24, 2024 going ex on Dec 29, 2023
Jan 02, 2024
Jan 24, 2024
Dec 29, 2023
Sep 21, 2023
A.NB Final Cash Dividend of gross USD 0.225 paid on Oct 25, 2023 going ex on Oct 02, 2023 with reinvestment option
Oct 03, 2023
Oct 25, 2023
Oct 02, 2023
May 18, 2023
A.NB Interim Cash Dividend of gross USD 0.225 paid on Jul 26, 2023 going ex on Jun 30, 2023 with reinvestment option
Jul 03, 2023
Jul 26, 2023
Jun 30, 2023
Feb 22, 2023
A.NB Interim Cash Dividend of gross USD 0.225 paid on Apr 26, 2023 going ex on Apr 03, 2023
Apr 04, 2023
Apr 26, 2023
Apr 03, 2023
Nov 16, 2022
A.NB Interim Cash Dividend of gross USD 0.225 paid on Jan 25, 2023 going ex on Dec 30, 2022
Jan 03, 2023
Jan 25, 2023
Dec 30, 2022
Sep 21, 2022
A.NB Final Cash Dividend of gross USD 0.21 paid on Oct 26, 2022 going ex on Oct 03, 2022
Oct 04, 2022
Oct 26, 2022
Oct 03, 2022
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
